10x Genomics (TXG) market cap

Market cap today
$7.41B

10x Genomics (TXG) has a market cap of $7.41B. At the end of fiscal 2025 (December 31, 2025) its market cap was $2.03B. That is 17.6% higher than the $1.73B of fiscal 2024. Today's figure is 264.0% above the fiscal 2025 year-end. Figures as of 18 Nov 2026, 10:54 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$7.41B
Market cap, fiscal 2025
$2.03B
Change on fiscal 2024
+17.6%
Growth, 5 years
−32.3% a year
Highest on record
$16.44Bfiscal 2021
Lowest on record
$1.73Bfiscal 2024
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

10x Genomics market cap, in more detail

Over the five fiscal years to 2025 the market cap shrank at a compound 32.3% a year. Across the 7 fiscal year-ends on record (2019–2025), the highest was $16.44B in fiscal 2021 and the lowest $1.73B in fiscal 2024.

History · 7 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

10x Genomics market cap, year by year

10x Genomics (TXG) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$7.41B—$56.30—
2025$2.03B 17.6% up$16.31124.75M
2024$1.73B 73.6% down$14.36120.45M
2023$6.56B 58.0% up$55.96117.17M
2022$4.15B 74.8% down$36.44113.86M
2021$16.44B 14.8% up$148.96110.35M
2020$14.32B 380.5% up$141.60101.15M
2019$2.98B—$76.2539.09M

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

Market cap at health care companies of similar size

Market cap of 10x Genomics and comparable companies
CompanyMarket cap
Twist Bioscience TWST$7.43B
Protagonist Therapeutics PTGX$8.14B
Krystal Biotech KRYS$8.85B
10x Genomics TXG$7.41B
HealthEquity HQY$8.42B
Corcept Therapeutics CORT$7.67B

Today's market value as the market data feed reports it, each in the currency its shares trade in.

More on TXG

10x Genomics, figure by figure

10x Genomics (TXG) overview: price, valuation and scorecardAll health care companies by market value

10x Genomics market cap: questions and answers

What is 10x Genomics's market cap?

10x Genomics (TXG) has a market cap of $7.41B. At the end of fiscal 2025 (December 31, 2025) its market cap was $2.03B. That is 17.6% higher than the $1.73B of fiscal 2024.

What is the growth rate of 10x Genomics's market cap?

Over the five fiscal years to 2025 the market cap shrank at a compound 32.3% a year.

What are the highest and lowest market cap figures on record for 10x Genomics?

Across the 7 fiscal year-ends on record (2019–2025), the highest was $16.44B in fiscal 2021 and the lowest $1.73B in fiscal 2024.

How is 10x Genomics's market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote. For 10x Genomics it is on record here for 7 fiscal years, 2019 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “10x Genomics (TXG) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/TXG/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.